Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.20.4
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Net sales (Note 4) $ 1,392,519 $ 376,562
Cost of sales 13,067,108 5,844,891
Gross loss (11,674,589) (5,468,329)
Operating expenses    
Selling, general and administrative 20,157,658 10,199,534
Research and development 9,148,931 8,199,074
Total operating expenses 29,306,589 18,398,608
Other income (Note 3, Note 14) 323,111,944 15,849,800
Income (loss) from operations 282,130,766 (8,017,137)
Interest expense, net 190,520,337 29,145,690
Income (loss) before provision for income taxes 91,610,429 (37,162,827)
Provision for income taxes (Note 8) 21,833,930 0
Net income (loss) $ 69,776,499 $ (37,162,827)
Net income (loss) attributable to common stockholders per share - basic (in usd per share) $ 0.75 $ (0.58)
Net income (loss) attributable to common stockholders per share - diluted (in usd per share) $ 0.70 $ (0.58)
Weighted average number of common shares outstanding - basic (in shares) 92,871,936 64,314,756
Weighted average number of common shares outstanding - diluted (in shares) 99,949,868 64,314,756